Log in

M&ABusinessLine

Sai Parenterals to buy majority stake in Bion Therapeutics

Positive+67

GreyOak summary

Sai Parenterals plans to acquire a majority stake in Hyderabad-based Bion Therapeutics through its subsidiary SP Analytics. The all-cash deal, expected to close by month-end, will make Bion a step-down subsidiary.

What it affects

Source

Read the original at BusinessLine

More Sai Parenterals news

No other recent stories about Sai Parenterals.

All Sai Parenterals news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy